nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—SLC15A2—melanoma	0.8	1	CbGaD
Ramipril—ACE—umbilical vein—melanoma	0.00575	0.153	CbGeAlD
Ramipril—ACE—hindlimb—melanoma	0.00527	0.14	CbGeAlD
Ramipril—ACE—arm—melanoma	0.00503	0.134	CbGeAlD
Ramipril—ACE—appendage—melanoma	0.00452	0.12	CbGeAlD
Ramipril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00387	0.294	CbGpPWpGaD
Ramipril—ACE—endothelium—melanoma	0.00273	0.0724	CbGeAlD
Ramipril—ACE—blood vessel—melanoma	0.00252	0.0668	CbGeAlD
Ramipril—ACE—neck—melanoma	0.0018	0.0478	CbGeAlD
Ramipril—SLC15A1—mammalian vulva—melanoma	0.00148	0.0393	CbGeAlD
Ramipril—ACE—eye—melanoma	0.00134	0.0355	CbGeAlD
Ramipril—SLC15A2—retina—melanoma	0.00116	0.0307	CbGeAlD
Ramipril—Fosinopril—SLC15A2—melanoma	0.00108	0.129	CrCbGaD
Ramipril—ACE—mammalian vulva—melanoma	0.00106	0.0282	CbGeAlD
Ramipril—Perindopril—SLC15A2—melanoma	0.000883	0.105	CrCbGaD
Ramipril—Spirapril—SLC15A2—melanoma	0.000873	0.104	CrCbGaD
Ramipril—BCHE—skin of body—melanoma	0.00086	0.0228	CbGeAlD
Ramipril—Moexipril—SLC15A2—melanoma	0.000837	0.0995	CrCbGaD
Ramipril—BCHE—mammalian vulva—melanoma	0.000785	0.0208	CbGeAlD
Ramipril—Quinapril—SLC15A2—melanoma	0.000778	0.0925	CrCbGaD
Ramipril—Cilazapril—SLC15A2—melanoma	0.000778	0.0925	CrCbGaD
Ramipril—ACE—head—melanoma	0.00076	0.0202	CbGeAlD
Ramipril—Trandolapril—SLC15A2—melanoma	0.000754	0.0896	CrCbGaD
Ramipril—Benazepril—SLC15A2—melanoma	0.000677	0.0804	CrCbGaD
Ramipril—SLC15A2—head—melanoma	0.000663	0.0176	CbGeAlD
Ramipril—BCHE—head—melanoma	0.000561	0.0149	CbGeAlD
Ramipril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000541	0.0411	CbGpPWpGaD
Ramipril—ACE—lymph node—melanoma	0.000532	0.0141	CbGeAlD
Ramipril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000522	0.0396	CbGpPWpGaD
Ramipril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000502	0.0381	CbGpPWpGaD
Ramipril—SLC15A2—lymph node—melanoma	0.000464	0.0123	CbGeAlD
Ramipril—Mitiglinide—PPARG—melanoma	0.000438	0.052	CrCbGaD
Ramipril—BCHE—lymph node—melanoma	0.000393	0.0104	CbGeAlD
Ramipril—Nateglinide—SLC15A2—melanoma	0.00039	0.0463	CrCbGaD
Ramipril—Atrial fibrillation—Docetaxel—melanoma	0.000378	0.00269	CcSEcCtD
Ramipril—Renal impairment—Docetaxel—melanoma	0.000377	0.00268	CcSEcCtD
Ramipril—Hepatitis—Temozolomide—melanoma	0.000373	0.00265	CcSEcCtD
Ramipril—Asthenia—Vemurafenib—melanoma	0.000372	0.00265	CcSEcCtD
Ramipril—Visual impairment—Carmustine—melanoma	0.000372	0.00265	CcSEcCtD
Ramipril—Oedema peripheral—Temozolomide—melanoma	0.000367	0.00261	CcSEcCtD
Ramipril—Cardiac failure—Docetaxel—melanoma	0.000367	0.00261	CcSEcCtD
Ramipril—Pruritus—Vemurafenib—melanoma	0.000367	0.00261	CcSEcCtD
Ramipril—Connective tissue disorder—Temozolomide—melanoma	0.000366	0.00261	CcSEcCtD
Ramipril—Alopecia—Dactinomycin—melanoma	0.000364	0.00259	CcSEcCtD
Ramipril—Hyponatraemia—Docetaxel—melanoma	0.00036	0.00256	CcSEcCtD
Ramipril—Visual impairment—Temozolomide—melanoma	0.000359	0.00256	CcSEcCtD
Ramipril—Erythema—Dactinomycin—melanoma	0.000359	0.00255	CcSEcCtD
Ramipril—Flushing—Carmustine—melanoma	0.000358	0.00255	CcSEcCtD
Ramipril—Ill-defined disorder—Bleomycin—melanoma	0.000357	0.00254	CcSEcCtD
Ramipril—Diarrhoea—Vemurafenib—melanoma	0.000355	0.00252	CcSEcCtD
Ramipril—Erythema multiforme—Temozolomide—melanoma	0.000353	0.00251	CcSEcCtD
Ramipril—Tinnitus—Temozolomide—melanoma	0.000348	0.00247	CcSEcCtD
Ramipril—Malaise—Bleomycin—melanoma	0.000347	0.00247	CcSEcCtD
Ramipril—Flushing—Temozolomide—melanoma	0.000346	0.00246	CcSEcCtD
Ramipril—Arrhythmia—Carmustine—melanoma	0.000345	0.00245	CcSEcCtD
Ramipril—Leukopenia—Bleomycin—melanoma	0.000344	0.00245	CcSEcCtD
Ramipril—Dizziness—Vemurafenib—melanoma	0.000343	0.00244	CcSEcCtD
Ramipril—Alopecia—Carmustine—melanoma	0.000341	0.00243	CcSEcCtD
Ramipril—Mental disorder—Carmustine—melanoma	0.000338	0.0024	CcSEcCtD
Ramipril—Immune system disorder—Temozolomide—melanoma	0.000337	0.0024	CcSEcCtD
Ramipril—Mediastinal disorder—Temozolomide—melanoma	0.000336	0.00239	CcSEcCtD
Ramipril—Malnutrition—Carmustine—melanoma	0.000336	0.00239	CcSEcCtD
Ramipril—Erythema—Carmustine—melanoma	0.000336	0.00239	CcSEcCtD
Ramipril—Cough—Bleomycin—melanoma	0.000336	0.00239	CcSEcCtD
Ramipril—Ill-defined disorder—Dactinomycin—melanoma	0.000333	0.00237	CcSEcCtD
Ramipril—Liver function test abnormal—Docetaxel—melanoma	0.000331	0.00235	CcSEcCtD
Ramipril—Vomiting—Vemurafenib—melanoma	0.00033	0.00234	CcSEcCtD
Ramipril—Alopecia—Temozolomide—melanoma	0.00033	0.00234	CcSEcCtD
Ramipril—Myalgia—Bleomycin—melanoma	0.000328	0.00233	CcSEcCtD
Ramipril—Chest pain—Bleomycin—melanoma	0.000328	0.00233	CcSEcCtD
Ramipril—Abdominal pain upper—Docetaxel—melanoma	0.000327	0.00233	CcSEcCtD
Ramipril—Orthostatic hypotension—Docetaxel—melanoma	0.000327	0.00233	CcSEcCtD
Ramipril—Rash—Vemurafenib—melanoma	0.000327	0.00233	CcSEcCtD
Ramipril—Mental disorder—Temozolomide—melanoma	0.000327	0.00232	CcSEcCtD
Ramipril—Dermatitis—Vemurafenib—melanoma	0.000327	0.00232	CcSEcCtD
Ramipril—Headache—Vemurafenib—melanoma	0.000325	0.00231	CcSEcCtD
Ramipril—Erythema—Temozolomide—melanoma	0.000325	0.00231	CcSEcCtD
Ramipril—Malnutrition—Temozolomide—melanoma	0.000325	0.00231	CcSEcCtD
Ramipril—Breast disorder—Docetaxel—melanoma	0.000324	0.0023	CcSEcCtD
Ramipril—Discomfort—Bleomycin—melanoma	0.000324	0.0023	CcSEcCtD
Ramipril—Malaise—Dactinomycin—melanoma	0.000324	0.0023	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000323	0.0023	CcSEcCtD
Ramipril—Cramp muscle—Docetaxel—melanoma	0.000323	0.0023	CcSEcCtD
Ramipril—Leukopenia—Dactinomycin—melanoma	0.000321	0.00229	CcSEcCtD
Ramipril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000319	0.0242	CbGpPWpGaD
Ramipril—Dysgeusia—Temozolomide—melanoma	0.000318	0.00226	CcSEcCtD
Ramipril—Confusional state—Bleomycin—melanoma	0.000317	0.00225	CcSEcCtD
Ramipril—Tremor—Carmustine—melanoma	0.000315	0.00224	CcSEcCtD
Ramipril—Oedema—Bleomycin—melanoma	0.000314	0.00223	CcSEcCtD
Ramipril—Anaphylactic shock—Bleomycin—melanoma	0.000314	0.00223	CcSEcCtD
Ramipril—Dysphagia—Docetaxel—melanoma	0.00031	0.0022	CcSEcCtD
Ramipril—Agitation—Carmustine—melanoma	0.000309	0.0022	CcSEcCtD
Ramipril—Nausea—Vemurafenib—melanoma	0.000308	0.00219	CcSEcCtD
Ramipril—Thrombocytopenia—Bleomycin—melanoma	0.000308	0.00219	CcSEcCtD
Ramipril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000307	0.0233	CbGpPWpGaD
Ramipril—Myalgia—Dactinomycin—melanoma	0.000306	0.00217	CcSEcCtD
Ramipril—Bronchospasm—Docetaxel—melanoma	0.000305	0.00217	CcSEcCtD
Ramipril—Tremor—Temozolomide—melanoma	0.000304	0.00216	CcSEcCtD
Ramipril—Discomfort—Dactinomycin—melanoma	0.000302	0.00215	CcSEcCtD
Ramipril—Angina pectoris—Docetaxel—melanoma	0.000302	0.00215	CcSEcCtD
Ramipril—Ill-defined disorder—Temozolomide—melanoma	0.000301	0.00214	CcSEcCtD
Ramipril—Leukopenia—Carmustine—melanoma	0.000301	0.00214	CcSEcCtD
Ramipril—Anorexia—Bleomycin—melanoma	0.000299	0.00213	CcSEcCtD
Ramipril—Agitation—Temozolomide—melanoma	0.000298	0.00212	CcSEcCtD
Ramipril—Angioedema—Temozolomide—melanoma	0.000297	0.00211	CcSEcCtD
Ramipril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000296	0.0224	CbGpPWpGaD
Ramipril—Pancytopenia—Docetaxel—melanoma	0.000294	0.00209	CcSEcCtD
Ramipril—Hypotension—Bleomycin—melanoma	0.000293	0.00209	CcSEcCtD
Ramipril—Oedema—Dactinomycin—melanoma	0.000293	0.00208	CcSEcCtD
Ramipril—Malaise—Temozolomide—melanoma	0.000293	0.00208	CcSEcCtD
Ramipril—Vertigo—Temozolomide—melanoma	0.000292	0.00207	CcSEcCtD
Ramipril—Convulsion—Carmustine—melanoma	0.000291	0.00207	CcSEcCtD
Ramipril—Leukopenia—Temozolomide—melanoma	0.000291	0.00207	CcSEcCtD
Ramipril—Neutropenia—Docetaxel—melanoma	0.00029	0.00206	CcSEcCtD
Ramipril—Palpitations—Temozolomide—melanoma	0.000287	0.00204	CcSEcCtD
Ramipril—Thrombocytopenia—Dactinomycin—melanoma	0.000287	0.00204	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000286	0.00204	CcSEcCtD
Ramipril—Chest pain—Carmustine—melanoma	0.000286	0.00203	CcSEcCtD
Ramipril—Myalgia—Carmustine—melanoma	0.000286	0.00203	CcSEcCtD
Ramipril—Anxiety—Carmustine—melanoma	0.000285	0.00203	CcSEcCtD
Ramipril—Cough—Temozolomide—melanoma	0.000283	0.00201	CcSEcCtD
Ramipril—Paraesthesia—Bleomycin—melanoma	0.000282	0.00201	CcSEcCtD
Ramipril—Weight increased—Docetaxel—melanoma	0.000282	0.00201	CcSEcCtD
Ramipril—Convulsion—Temozolomide—melanoma	0.000281	0.002	CcSEcCtD
Ramipril—Dyspnoea—Bleomycin—melanoma	0.00028	0.00199	CcSEcCtD
Ramipril—Anorexia—Dactinomycin—melanoma	0.000279	0.00199	CcSEcCtD
Ramipril—Confusional state—Carmustine—melanoma	0.000276	0.00197	CcSEcCtD
Ramipril—Myalgia—Temozolomide—melanoma	0.000276	0.00197	CcSEcCtD
Ramipril—Arthralgia—Temozolomide—melanoma	0.000276	0.00197	CcSEcCtD
Ramipril—Anxiety—Temozolomide—melanoma	0.000275	0.00196	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000274	0.00195	CcSEcCtD
Ramipril—Oedema—Carmustine—melanoma	0.000274	0.00195	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000274	0.00195	CcSEcCtD
Ramipril—Discomfort—Temozolomide—melanoma	0.000273	0.00194	CcSEcCtD
Ramipril—Decreased appetite—Bleomycin—melanoma	0.000273	0.00194	CcSEcCtD
Ramipril—Acute coronary syndrome—Docetaxel—melanoma	0.000272	0.00194	CcSEcCtD
Ramipril—Renal failure—Docetaxel—melanoma	0.000272	0.00193	CcSEcCtD
Ramipril—Neuropathy peripheral—Docetaxel—melanoma	0.000271	0.00193	CcSEcCtD
Ramipril—Myocardial infarction—Docetaxel—melanoma	0.000271	0.00193	CcSEcCtD
Ramipril—Dry mouth—Temozolomide—melanoma	0.00027	0.00192	CcSEcCtD
Ramipril—Stomatitis—Docetaxel—melanoma	0.000269	0.00192	CcSEcCtD
Ramipril—Jaundice—Docetaxel—melanoma	0.000269	0.00192	CcSEcCtD
Ramipril—Conjunctivitis—Docetaxel—melanoma	0.000269	0.00191	CcSEcCtD
Ramipril—Thrombocytopenia—Carmustine—melanoma	0.000268	0.00191	CcSEcCtD
Ramipril—Tachycardia—Carmustine—melanoma	0.000268	0.0019	CcSEcCtD
Ramipril—Confusional state—Temozolomide—melanoma	0.000267	0.0019	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000267	0.0019	CcSEcCtD
Ramipril—Anaphylactic shock—Temozolomide—melanoma	0.000265	0.00188	CcSEcCtD
Ramipril—Oedema—Temozolomide—melanoma	0.000265	0.00188	CcSEcCtD
Ramipril—Anorexia—Carmustine—melanoma	0.000261	0.00186	CcSEcCtD
Ramipril—Hepatobiliary disease—Docetaxel—melanoma	0.000261	0.00186	CcSEcCtD
Ramipril—Epistaxis—Docetaxel—melanoma	0.000261	0.00185	CcSEcCtD
Ramipril—Nervous system disorder—Temozolomide—melanoma	0.00026	0.00185	CcSEcCtD
Ramipril—Thrombocytopenia—Temozolomide—melanoma	0.000259	0.00185	CcSEcCtD
Ramipril—Feeling abnormal—Bleomycin—melanoma	0.000259	0.00184	CcSEcCtD
Ramipril—Agranulocytosis—Docetaxel—melanoma	0.000258	0.00183	CcSEcCtD
Ramipril—Skin disorder—Temozolomide—melanoma	0.000257	0.00183	CcSEcCtD
Ramipril—Hypotension—Carmustine—melanoma	0.000256	0.00182	CcSEcCtD
Ramipril—ACE—Peptide hormone metabolism—PAX6—melanoma	0.000256	0.0194	CbGpPWpGaD
Ramipril—Hyperhidrosis—Temozolomide—melanoma	0.000256	0.00182	CcSEcCtD
Ramipril—Decreased appetite—Dactinomycin—melanoma	0.000255	0.00181	CcSEcCtD
Ramipril—Fatigue—Dactinomycin—melanoma	0.000253	0.0018	CcSEcCtD
Ramipril—Anorexia—Temozolomide—melanoma	0.000253	0.0018	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Carmustine—melanoma	0.00025	0.00178	CcSEcCtD
Ramipril—Urticaria—Bleomycin—melanoma	0.00025	0.00177	CcSEcCtD
Ramipril—Body temperature increased—Bleomycin—melanoma	0.000248	0.00177	CcSEcCtD
Ramipril—Hepatitis—Docetaxel—melanoma	0.000248	0.00176	CcSEcCtD
Ramipril—Insomnia—Carmustine—melanoma	0.000248	0.00176	CcSEcCtD
Ramipril—Paraesthesia—Carmustine—melanoma	0.000246	0.00175	CcSEcCtD
Ramipril—Dyspnoea—Carmustine—melanoma	0.000244	0.00174	CcSEcCtD
Ramipril—Oedema peripheral—Docetaxel—melanoma	0.000244	0.00174	CcSEcCtD
Ramipril—Somnolence—Carmustine—melanoma	0.000244	0.00173	CcSEcCtD
Ramipril—Connective tissue disorder—Docetaxel—melanoma	0.000244	0.00173	CcSEcCtD
Ramipril—Feeling abnormal—Dactinomycin—melanoma	0.000241	0.00172	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000241	0.00172	CcSEcCtD
Ramipril—Insomnia—Temozolomide—melanoma	0.00024	0.0017	CcSEcCtD
Ramipril—Gastrointestinal pain—Dactinomycin—melanoma	0.00024	0.0017	CcSEcCtD
Ramipril—Visual impairment—Docetaxel—melanoma	0.000239	0.0017	CcSEcCtD
Ramipril—Decreased appetite—Carmustine—melanoma	0.000238	0.0017	CcSEcCtD
Ramipril—Paraesthesia—Temozolomide—melanoma	0.000238	0.00169	CcSEcCtD
Ramipril—Gastrointestinal disorder—Carmustine—melanoma	0.000237	0.00168	CcSEcCtD
Ramipril—Dyspnoea—Temozolomide—melanoma	0.000236	0.00168	CcSEcCtD
Ramipril—Somnolence—Temozolomide—melanoma	0.000236	0.00168	CcSEcCtD
Ramipril—Erythema multiforme—Docetaxel—melanoma	0.000234	0.00167	CcSEcCtD
Ramipril—Constipation—Carmustine—melanoma	0.000234	0.00167	CcSEcCtD
Ramipril—Dyspepsia—Temozolomide—melanoma	0.000233	0.00166	CcSEcCtD
Ramipril—Abdominal pain—Dactinomycin—melanoma	0.000232	0.00165	CcSEcCtD
Ramipril—Body temperature increased—Dactinomycin—melanoma	0.000232	0.00165	CcSEcCtD
Ramipril—Hypersensitivity—Bleomycin—melanoma	0.000231	0.00165	CcSEcCtD
Ramipril—Decreased appetite—Temozolomide—melanoma	0.00023	0.00164	CcSEcCtD
Ramipril—Flushing—Docetaxel—melanoma	0.00023	0.00164	CcSEcCtD
Ramipril—Gastrointestinal disorder—Temozolomide—melanoma	0.000229	0.00163	CcSEcCtD
Ramipril—Fatigue—Temozolomide—melanoma	0.000228	0.00162	CcSEcCtD
Ramipril—Constipation—Temozolomide—melanoma	0.000227	0.00161	CcSEcCtD
Ramipril—Feeling abnormal—Carmustine—melanoma	0.000226	0.00161	CcSEcCtD
Ramipril—Asthenia—Bleomycin—melanoma	0.000225	0.0016	CcSEcCtD
Ramipril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000225	0.017	CbGpPWpGaD
Ramipril—Gastrointestinal pain—Carmustine—melanoma	0.000224	0.00159	CcSEcCtD
Ramipril—Immune system disorder—Docetaxel—melanoma	0.000224	0.00159	CcSEcCtD
Ramipril—Mediastinal disorder—Docetaxel—melanoma	0.000223	0.00159	CcSEcCtD
Ramipril—Nateglinide—PPARG—melanoma	0.000223	0.0265	CrCbGaD
Ramipril—Pruritus—Bleomycin—melanoma	0.000222	0.00158	CcSEcCtD
Ramipril—Arrhythmia—Docetaxel—melanoma	0.000222	0.00158	CcSEcCtD
Ramipril—Alopecia—Docetaxel—melanoma	0.000219	0.00156	CcSEcCtD
Ramipril—Feeling abnormal—Temozolomide—melanoma	0.000218	0.00155	CcSEcCtD
Ramipril—Mental disorder—Docetaxel—melanoma	0.000217	0.00155	CcSEcCtD
Ramipril—Abdominal pain—Carmustine—melanoma	0.000217	0.00154	CcSEcCtD
Ramipril—Body temperature increased—Carmustine—melanoma	0.000217	0.00154	CcSEcCtD
Ramipril—Gastrointestinal pain—Temozolomide—melanoma	0.000217	0.00154	CcSEcCtD
Ramipril—BCHE—Irinotecan Pathway—APC—melanoma	0.000216	0.0164	CbGpPWpGaD
Ramipril—Malnutrition—Docetaxel—melanoma	0.000216	0.00154	CcSEcCtD
Ramipril—Erythema—Docetaxel—melanoma	0.000216	0.00154	CcSEcCtD
Ramipril—Hypersensitivity—Dactinomycin—melanoma	0.000216	0.00154	CcSEcCtD
Ramipril—Dysgeusia—Docetaxel—melanoma	0.000211	0.0015	CcSEcCtD
Ramipril—Urticaria—Temozolomide—melanoma	0.00021	0.0015	CcSEcCtD
Ramipril—Asthenia—Dactinomycin—melanoma	0.00021	0.00149	CcSEcCtD
Ramipril—Abdominal pain—Temozolomide—melanoma	0.000209	0.00149	CcSEcCtD
Ramipril—Body temperature increased—Temozolomide—melanoma	0.000209	0.00149	CcSEcCtD
Ramipril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000208	0.0158	CbGpPWpGaD
Ramipril—Muscle spasms—Docetaxel—melanoma	0.000208	0.00148	CcSEcCtD
Ramipril—Hypersensitivity—Carmustine—melanoma	0.000202	0.00144	CcSEcCtD
Ramipril—Diarrhoea—Dactinomycin—melanoma	0.0002	0.00143	CcSEcCtD
Ramipril—Vomiting—Bleomycin—melanoma	0.0002	0.00142	CcSEcCtD
Ramipril—Rash—Bleomycin—melanoma	0.000198	0.00141	CcSEcCtD
Ramipril—Dermatitis—Bleomycin—melanoma	0.000198	0.00141	CcSEcCtD
Ramipril—Asthenia—Carmustine—melanoma	0.000197	0.0014	CcSEcCtD
Ramipril—Hypersensitivity—Temozolomide—melanoma	0.000195	0.00139	CcSEcCtD
Ramipril—Syncope—Docetaxel—melanoma	0.000194	0.00138	CcSEcCtD
Ramipril—Leukopenia—Docetaxel—melanoma	0.000193	0.00137	CcSEcCtD
Ramipril—Palpitations—Docetaxel—melanoma	0.000191	0.00136	CcSEcCtD
Ramipril—Asthenia—Temozolomide—melanoma	0.00019	0.00135	CcSEcCtD
Ramipril—Loss of consciousness—Docetaxel—melanoma	0.00019	0.00135	CcSEcCtD
Ramipril—Cough—Docetaxel—melanoma	0.000188	0.00134	CcSEcCtD
Ramipril—Diarrhoea—Carmustine—melanoma	0.000188	0.00133	CcSEcCtD
Ramipril—Pruritus—Temozolomide—melanoma	0.000187	0.00133	CcSEcCtD
Ramipril—Convulsion—Docetaxel—melanoma	0.000187	0.00133	CcSEcCtD
Ramipril—Nausea—Bleomycin—melanoma	0.000187	0.00133	CcSEcCtD
Ramipril—Vomiting—Dactinomycin—melanoma	0.000186	0.00132	CcSEcCtD
Ramipril—Rash—Dactinomycin—melanoma	0.000185	0.00131	CcSEcCtD
Ramipril—Myalgia—Docetaxel—melanoma	0.000184	0.00131	CcSEcCtD
Ramipril—Chest pain—Docetaxel—melanoma	0.000184	0.00131	CcSEcCtD
Ramipril—Arthralgia—Docetaxel—melanoma	0.000184	0.00131	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000183	0.0013	CcSEcCtD
Ramipril—Perindopril—ABCB1—melanoma	0.000181	0.0215	CrCbGaD
Ramipril—Dizziness—Carmustine—melanoma	0.000181	0.00129	CcSEcCtD
Ramipril—Diarrhoea—Temozolomide—melanoma	0.000181	0.00129	CcSEcCtD
Ramipril—Dry mouth—Docetaxel—melanoma	0.00018	0.00128	CcSEcCtD
Ramipril—Confusional state—Docetaxel—melanoma	0.000178	0.00126	CcSEcCtD
Ramipril—Anaphylactic shock—Docetaxel—melanoma	0.000176	0.00125	CcSEcCtD
Ramipril—Oedema—Docetaxel—melanoma	0.000176	0.00125	CcSEcCtD
Ramipril—Dizziness—Temozolomide—melanoma	0.000175	0.00125	CcSEcCtD
Ramipril—Vomiting—Carmustine—melanoma	0.000174	0.00124	CcSEcCtD
Ramipril—Nausea—Dactinomycin—melanoma	0.000174	0.00124	CcSEcCtD
Ramipril—Shock—Docetaxel—melanoma	0.000173	0.00123	CcSEcCtD
Ramipril—Rash—Carmustine—melanoma	0.000173	0.00123	CcSEcCtD
Ramipril—Nervous system disorder—Docetaxel—melanoma	0.000173	0.00123	CcSEcCtD
Ramipril—Dermatitis—Carmustine—melanoma	0.000173	0.00123	CcSEcCtD
Ramipril—Thrombocytopenia—Docetaxel—melanoma	0.000173	0.00123	CcSEcCtD
Ramipril—Tachycardia—Docetaxel—melanoma	0.000172	0.00122	CcSEcCtD
Ramipril—Headache—Carmustine—melanoma	0.000172	0.00122	CcSEcCtD
Ramipril—Skin disorder—Docetaxel—melanoma	0.000171	0.00122	CcSEcCtD
Ramipril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—melanoma	0.00017	0.0129	CbGpPWpGaD
Ramipril—Vomiting—Temozolomide—melanoma	0.000168	0.0012	CcSEcCtD
Ramipril—Anorexia—Docetaxel—melanoma	0.000168	0.00119	CcSEcCtD
Ramipril—Rash—Temozolomide—melanoma	0.000167	0.00119	CcSEcCtD
Ramipril—Dermatitis—Temozolomide—melanoma	0.000167	0.00119	CcSEcCtD
Ramipril—Headache—Temozolomide—melanoma	0.000166	0.00118	CcSEcCtD
Ramipril—Hypotension—Docetaxel—melanoma	0.000165	0.00117	CcSEcCtD
Ramipril—Nausea—Carmustine—melanoma	0.000163	0.00116	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000161	0.00114	CcSEcCtD
Ramipril—Cilazapril—ABCB1—melanoma	0.00016	0.019	CrCbGaD
Ramipril—Lisinopril—ABCB1—melanoma	0.00016	0.019	CrCbGaD
Ramipril—Insomnia—Docetaxel—melanoma	0.000159	0.00113	CcSEcCtD
Ramipril—Paraesthesia—Docetaxel—melanoma	0.000158	0.00113	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—ADAMTS20—melanoma	0.000158	0.012	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—PIGU—melanoma	0.000158	0.012	CbGpPWpGaD
Ramipril—Nausea—Temozolomide—melanoma	0.000157	0.00112	CcSEcCtD
Ramipril—Dyspnoea—Docetaxel—melanoma	0.000157	0.00112	CcSEcCtD
Ramipril—Somnolence—Docetaxel—melanoma	0.000157	0.00111	CcSEcCtD
Ramipril—Dyspepsia—Docetaxel—melanoma	0.000155	0.0011	CcSEcCtD
Ramipril—BCHE—Glycerophospholipid biosynthesis—GPAM—melanoma	0.000154	0.0117	CbGpPWpGaD
Ramipril—Decreased appetite—Docetaxel—melanoma	0.000153	0.00109	CcSEcCtD
Ramipril—Gastrointestinal disorder—Docetaxel—melanoma	0.000152	0.00108	CcSEcCtD
Ramipril—Fatigue—Docetaxel—melanoma	0.000152	0.00108	CcSEcCtD
Ramipril—Constipation—Docetaxel—melanoma	0.000151	0.00107	CcSEcCtD
Ramipril—Feeling abnormal—Docetaxel—melanoma	0.000145	0.00103	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—ARL2—melanoma	0.000144	0.011	CbGpPWpGaD
Ramipril—Gastrointestinal pain—Docetaxel—melanoma	0.000144	0.00102	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000143	0.0109	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000142	0.0108	CbGpPWpGaD
Ramipril—Body temperature increased—Docetaxel—melanoma	0.000139	0.000991	CcSEcCtD
Ramipril—Abdominal pain—Docetaxel—melanoma	0.000139	0.000991	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—PIP4K2A—melanoma	0.000138	0.0105	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000137	0.0104	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000133	0.0101	CbGpPWpGaD
Ramipril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000132	0.01	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000132	0.01	CbGpPWpGaD
Ramipril—BCHE—Glycerophospholipid biosynthesis—PLA2G6—melanoma	0.000131	0.00996	CbGpPWpGaD
Ramipril—Hypersensitivity—Docetaxel—melanoma	0.00013	0.000923	CcSEcCtD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000129	0.00981	CbGpPWpGaD
Ramipril—Asthenia—Docetaxel—melanoma	0.000126	0.000899	CcSEcCtD
Ramipril—Pruritus—Docetaxel—melanoma	0.000125	0.000887	CcSEcCtD
Ramipril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000123	0.00932	CbGpPWpGaD
Ramipril—Diarrhoea—Docetaxel—melanoma	0.000121	0.000857	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00012	0.0091	CbGpPWpGaD
Ramipril—Enalapril—ABCB1—melanoma	0.000117	0.0139	CrCbGaD
Ramipril—ACE—Peptide hormone metabolism—IGF1—melanoma	0.000117	0.00885	CbGpPWpGaD
Ramipril—Dizziness—Docetaxel—melanoma	0.000117	0.000829	CcSEcCtD
Ramipril—Vomiting—Docetaxel—melanoma	0.000112	0.000797	CcSEcCtD
Ramipril—Rash—Docetaxel—melanoma	0.000111	0.00079	CcSEcCtD
Ramipril—Dermatitis—Docetaxel—melanoma	0.000111	0.000789	CcSEcCtD
Ramipril—Headache—Docetaxel—melanoma	0.00011	0.000785	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—GPAM—melanoma	0.000108	0.00817	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—SLC17A5—melanoma	0.000105	0.00799	CbGpPWpGaD
Ramipril—Nausea—Docetaxel—melanoma	0.000105	0.000744	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—PAX6—melanoma	0.000103	0.0078	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000103	0.00778	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ADAMTS13—melanoma	0.000102	0.00772	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	9.92e-05	0.00753	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	9.2e-05	0.00698	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PLA2G6—melanoma	9.16e-05	0.00695	CbGpPWpGaD
Ramipril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	8.65e-05	0.00656	CbGpPWpGaD
Ramipril—Nateglinide—ALB—melanoma	8.39e-05	0.00997	CrCbGaD
Ramipril—BCHE—Neuronal System—SLC6A11—melanoma	7.86e-05	0.00596	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—RPS3—melanoma	7.58e-05	0.00576	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ACER3—melanoma	7.33e-05	0.00556	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	7.23e-05	0.00549	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	6.97e-05	0.00529	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	6.71e-05	0.00509	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	6.57e-05	0.00498	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ADAMTS20—melanoma	6.34e-05	0.00481	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PIGU—melanoma	6.34e-05	0.00481	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—GRIN2A—melanoma	6.26e-05	0.00475	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	6.1e-05	0.00463	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	5.91e-05	0.00449	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ARL2—melanoma	5.79e-05	0.0044	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	5.49e-05	0.00416	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—PAX6—melanoma	4.84e-05	0.00367	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—GRIN2A—melanoma	4.8e-05	0.00364	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—IGF1—melanoma	4.68e-05	0.00355	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—HSPA5—melanoma	4.65e-05	0.00353	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	4.44e-05	0.00337	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—SLC17A5—melanoma	4.23e-05	0.00321	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ADAMTS13—melanoma	4.08e-05	0.0031	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.71e-05	0.00281	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—CTNNB1—melanoma	3.47e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CG—melanoma	3.47e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.47e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—PRKCA—melanoma	3.29e-05	0.0025	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACER3—melanoma	3.27e-05	0.00248	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CD—melanoma	3.05e-05	0.00231	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—RPS3—melanoma	3.04e-05	0.00231	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	3e-05	0.00228	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UGT2B10—melanoma	2.99e-05	0.00227	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.95e-05	0.00224	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	2.82e-05	0.00214	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.79e-05	0.00212	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HS3ST5—melanoma	2.78e-05	0.00211	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—MMP1—melanoma	2.75e-05	0.00209	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CB—melanoma	2.66e-05	0.00202	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	2.62e-05	0.00199	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—PRKCA—melanoma	2.52e-05	0.00191	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	2.42e-05	0.00184	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PTEN—melanoma	2.3e-05	0.00174	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	2.29e-05	0.00174	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.23e-05	0.0017	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—IGF1—melanoma	2.2e-05	0.00167	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—MMP2—melanoma	2.13e-05	0.00162	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	2.13e-05	0.00161	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PLCB4—melanoma	2.1e-05	0.0016	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	2.07e-05	0.00157	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	2.03e-05	0.00154	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC6A11—melanoma	1.98e-05	0.0015	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIP4K2A—melanoma	1.98e-05	0.0015	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PAX6—melanoma	1.94e-05	0.00147	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTAP—melanoma	1.92e-05	0.00146	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.88e-05	0.00143	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—HSPA5—melanoma	1.87e-05	0.00142	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—BRAF—melanoma	1.86e-05	0.00141	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CXCL8—melanoma	1.77e-05	0.00134	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PHGDH—melanoma	1.72e-05	0.0013	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LUM—melanoma	1.72e-05	0.0013	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HPSE—melanoma	1.68e-05	0.00128	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CUBN—melanoma	1.65e-05	0.00125	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CTNNB1—melanoma	1.63e-05	0.00124	CbGpPWpGaD
Ramipril—BCHE—Phospholipid metabolism—PIK3CA—melanoma	1.62e-05	0.00123	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SDHD—melanoma	1.59e-05	0.00121	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CSPG4—melanoma	1.59e-05	0.00121	CbGpPWpGaD
Ramipril—BCHE—Metabolism—BSG—melanoma	1.59e-05	0.00121	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—MDM2—melanoma	1.56e-05	0.00118	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GPAM—melanoma	1.54e-05	0.00117	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	1.43e-05	0.00109	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	1.39e-05	0.00105	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	1.33e-05	0.00101	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PLA2G6—melanoma	1.31e-05	0.000997	CbGpPWpGaD
Ramipril—BCHE—Metabolism—VCAN—melanoma	1.18e-05	0.000895	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.12e-05	0.000847	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	1.11e-05	0.000845	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MMP1—melanoma	1.1e-05	0.000838	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.08e-05	0.000818	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—MAPK1—melanoma	1.06e-05	0.000807	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP17A1—melanoma	9.95e-06	0.000755	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.82e-06	0.000745	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	9.69e-06	0.000735	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GNA11—melanoma	9.4e-06	0.000713	CbGpPWpGaD
Ramipril—BCHE—Metabolism—FASN—melanoma	9.2e-06	0.000698	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A5—melanoma	9.05e-06	0.000687	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF1—melanoma	8.83e-06	0.00067	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GNAQ—melanoma	8.74e-06	0.000663	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CD44—melanoma	8.74e-06	0.000663	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.56e-06	0.000649	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MMP2—melanoma	8.55e-06	0.000649	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—HRAS—melanoma	8.53e-06	0.000648	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.48e-06	0.000643	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1B1—melanoma	8.38e-06	0.000636	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.39e-06	0.000561	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CXCL8—melanoma	7.1e-06	0.000539	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ABCB1—melanoma	6.9e-06	0.000524	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CTNNB1—melanoma	6.55e-06	0.000497	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PRKCA—melanoma	6.35e-06	0.000482	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ERCC2—melanoma	6.3e-06	0.000478	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.22e-06	0.000396	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CG—melanoma	4.97e-06	0.000377	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARG—melanoma	4.8e-06	0.000364	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CD—melanoma	4.37e-06	0.000332	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ALB—melanoma	4.32e-06	0.000328	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CB—melanoma	3.81e-06	0.000289	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGS2—melanoma	3.78e-06	0.000287	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTEN—melanoma	3.29e-06	0.00025	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3CA—melanoma	2.32e-06	0.000176	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKT1—melanoma	1.9e-06	0.000144	CbGpPWpGaD
